{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "18019 Intranasal Ketamine  1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "INTRANASAL KETAMINE"
                    },
                    {
                        "text": "Type: Clinical Guideline Register No: 18019 Status: Public"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 3,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Best Practice"
                    },
                    {
                        "text": "Contributes to CQC Outcome number:"
                    },
                    {
                        "text": "4 and 9"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 4,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With:"
                    },
                    {
                        "text": "Post/Committee/Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Pain Consultants"
                    },
                    {
                        "text": "Dr Tom Durcan"
                    },
                    {
                        "text": "6th August 2018"
                    },
                    {
                        "text": "Service Manager"
                    },
                    {
                        "text": "Lynne Mustard"
                    },
                    {
                        "text": "6th August 2018"
                    },
                    {
                        "text": "Pain Pharmacist"
                    },
                    {
                        "text": "Alison Bloor"
                    },
                    {
                        "text": "6th August 2018"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Professionally Approved By:"
                    },
                    {
                        "text": "Dr Mark Alexander-Williams"
                    },
                    {
                        "text": "Pain Consultant"
                    },
                    {
                        "text": "6th August 2018"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 11,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Version Number"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Issuing Directorate"
                    },
                    {
                        "text": "Division 3: Integrated Pain Management Service"
                    },
                    {
                        "text": "Ratified by:"
                    },
                    {
                        "text": "DRAG Chairman's Action"
                    },
                    {
                        "text": "Ratified on:"
                    },
                    {
                        "text": "3rd October 2018"
                    },
                    {
                        "text": "Implementation Date"
                    },
                    {
                        "text": "8th October 2018"
                    },
                    {
                        "text": "Next Review Date"
                    },
                    {
                        "text": "7th October 2021"
                    },
                    {
                        "text": "Executive Management Group"
                    },
                    {
                        "text": "October 2018"
                    },
                    {
                        "text": "Author/Contact for Information"
                    },
                    {
                        "text": "Lynne Mustard, Lead CNS Pain Team"
                    },
                    {
                        "text": "Policy to be followed by (target staff)"
                    },
                    {
                        "text": "Medical and nursing staff"
                    },
                    {
                        "text": "Distribution Method"
                    },
                    {
                        "text": "Available on the intranet and website"
                    },
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Policy for the Use of Medicines 08083 Controlled Drug Policy 06006 Patient Observation Policy 04080 Consent Policy"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "Document Review History:"
            }
        },
        {
            "type": "table",
            "sequence_num": 8,
            "data": {
                "num_rows": 4,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewed by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Lynne Mustard"
                    },
                    {
                        "text": "8th October 2018"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "text": "Index"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "prefix": 1.1,
                "text": "To provide a guideline for the administration of intranasal ketamine for selected patients during an inpatient episode in response to pain presentations that are difficult to manage with routine analgesic strategies."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "prefix": 2.1,
                "text": "Mid Essex Hospital Services NHS Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "This guideline is for the use of trained and competent registered nurses"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 0,
                "prefix": 3.2,
                "text": "Selection of patients is the remit of the Pain Service only."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 0,
                "prefix": 3.3,
                "text": "The ward manager is responsible for adequate stock to be procured and stored under the Controlled Drug (CD) Policy in liaison with the ward pharmacist."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "Registered nurses involved in the care of patients receiving intranasal (IN) ketamine employed within the Trust are required to be knowledgeable about the pharmacokinetics of the drug ketamine and proficient in intranasal administration thereof, in accordance with the NMC Code."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "Training is available from the Pain Service."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Registered nurses administering IN ketamine shall be responsible for the correct checking and administration procedures in accordance with CD policy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Staff who administer IN ketamine are personally accountable for their own actions with due regard for professional governing bodies."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Patient selection is the remit of the Pain Service only."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "The nurse administering the IN ketamine is responsible for providing an explanation of the drug and its actions to the satisfaction of the patient thereby securing verbal consent."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "The nurse administering the IN ketamine is responsible for overseeing the IN administration to its effective completion"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "prefix": 5.6,
                "text": "The nurse administering the IN ketamine is responsible for monitoring or the delegation thereof to observe effect and/or adverse effects and act appropriately on them"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Routine handwashing before and after administering the IN ketamine is to be observed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "The used IN device is to be disposed of as clinical waste."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "All checking procedures are to be performed in line with the CD Policy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "Prescription charts should be completed by the Pain Consultant or an advocate thereof, under Pain Service instruction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "text": "8.1.1 IN ketamine is chosen in specific circumstances and for a limited period of time during an inpatient's stay. The Pain Consultant will decide on suitability of the patient. Criteria may include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "text": "Neuropathic pain unresponsive to routine anti-neuropathic drugs"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "text": "Hyperalgesia/allodynia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "text": "Poor response to opioids post operatively"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "text": "History of high opioid consumption peri-operatively"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "text": "8.1.2 Contraindications include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "text": "Evidenced allergy to the drug"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "text": "Hypertension"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "text": "Pregnancy +/- pre-eclampsia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "text": "Cerebral trauma/cerebro-vascular accident (CVA)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "text": "Alcohol/drug dependence (relative)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "The patient is informed of the drug, its actions, possible adverse effects and how to administer it intranasally."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "Verbal consent is then acknowledged in order to proceed"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "All CD checking in line with Trust Policy is adhered to"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "Patient specific IN device used to administer in accordance with the dose prescribed: 7mg bolus x 1 or 2 (range of 0.07mg/kg to 0.28mg/kg prescribed three times a day or four times a day: total 0.21mg/kg/day to 1.12mg/kg/day)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Document, record and sign for IN ketamine administered in line with CD Policy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "prefix": 30.0,
                "text": "Monitor for pain relief, cognition, blood pressure, pulse and respirations immediately after administration and every  minutes for 2 hours: if adverse effects discontinue prescription, reassure patient and inform Pain Service"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Clinical risk is low for this dose and preparation of ketamine. Dissociation and psychological disturbances such as delusions and \u2018flash backs' to trauma have been reported in rare cases."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "If such reaction is observed, medical assistance is required and a benzodiazepine can be given if necessary to allay these temporary symptoms."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "A risk event form must be completed in all instances of non-compliance with this guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "Clinical observation and monitoring is the remit of the ward staff involved in the patient's care."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "Clinical records must reflect the usage and efficacy and clinical response to the analgesic regime"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "prefix": 13.3,
                "text": "Concurrent opioids should be weaned in advance of stopping the ketamine before discharge from hospital : seek guidance from the Pain Service"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "prefix": 13.4,
                "text": "Inpatients prescribed IN ketamine will be monitored by the Pain Service until discharge and followed up as an outpatient if required."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "text": "Shug S. New uses for an old drug: the role of ketamine in post-operative pain management. ASEAN Journal of Anaesthesiology 2004; 5: 39 \u2013 42"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "text": "Tomlinson A. Ketamine.http://www.nda.ox.ac.uk/wfsa/html/u04/u04/_010.htm"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "text": "McCartney CJL, Sinha A, Katz J. A qualitative systematic review of the role of N-Mthyl-d-Aspartate receptor antagonists in preventive analgesia. Anesth Analg 2004; 98: 1385 \u2013 400"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "text": "Subraniam K, Subraniam S, Steinbrook RA. Ketamine as an adjuvent to analgesic opioids: A quantitative and qualitative systematic review. Anesth Analg 2004; 99: 482 - 95"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology, th Edn. London: Churchill Livingstone, 2003"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "text": "Tobias JD. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Critical Care Medicine 2000; 28: 2122 \u2013 32"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "text": "Mitchell AC. Generalized hyperalgesia and allodynia following abrupt cessation of subcutaneous ketamine infusion. Palliative Medicine 1999; 13: 427 - 8"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Lim DK. Ketamine associated psychedelic effects and dependence. Singapore Medical Journal 2003; 44: 31-"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "text": "Pal HR, Berry N, Kumar R, Ray R. Ketamine dependence. Anaesthesia and Intensive Care 2002; 30: 382 - 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        }
    ]
}